Compugen Stock

Compugen Liabilities

Delisted·Jun 15, 2026

The The Liabilities of Compugen (CGEN) as of Jul 18, 2026 is 53.84 M USD. In the previous year, The Liabilities was 60.08 M USD — a change of -10.39% (lower).

Liabilities

53.84 MUSD

YoY

-10.39%

Last updated:

In 2026, Compugen's total liabilities amounted to 53.84 M USD, a -10.39% difference from the 60.08 M USD total liabilities in the previous year.

Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Compugen's Liabilities

Compugen's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Compugen's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Compugen's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Compugen's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Compugen’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Compugen stock

The Liabilities of Compugen is 53.84 M USD in 2026.

Access this data via the Eulerpool API

Balance Sheet — Compugen

All Key Metrics — Compugen